- Nevro press release ( NYSE: NVRO ): Q4 GAAP EPS of -$0.54 misses by $0.05 .
- Revenue of $113.84M (+10.8% Y/Y) beats by $0.14M .
- Provides First Quarter 2023 Revenue Guidance of $94 Million to $96 Million Representing 9% to 11% Constant Currency Growth; Reiterates Full-Year 2023 Revenue Guidance of $445 Million to $455 Million, or 10% to 13% Constant Currency Growth Over 2022; Full-Year 2023 Guidance Includes PDN Indication Sales of Approximately $75 Million to $85 Million, or 56% to 77% Growth Over 2022
- Provides First Quarter of 2023 Non-GAAP Adjusted EBITDA Guidance of Negative $19 Million to Negative $20 Million and Full-Year 2023 Non-GAAP Adjusted EBITDA Guidance of Negative $5 Million to Negative $10 Million.
For further details see:
Nevro GAAP EPS of -$0.54 misses by $0.05, revenue of $113.84M beats by $0.14M